Etoposide — 100MG, Injection, box of 1 × 5 mL vial

Etoposide — 100MG, Injection, box of 1 × 5 mL vial

Etoposide is a injection for intravenous use. Etoposide Injection, USP is indicated in the management of the following neoplasms: Refractory Testicular Tumors Etoposide injection in combination therapy with other approved chemotherapeutic agents in patients with refractory testicular tumors who have already received appropriate surgical, chemotherapeutic, and radiotherapeutic therapy. Small Cell Lung Cancer Etoposide injection and/or capsules in combination with other approved chemotherapeutic agents as first line treatment in patients with small cell lung cancer.

• Active ingredient or product type: ETOPOSIDE
• Strength/concentration: 100MG
• Dosage form and route: Injection, Intravenous
• Exact package presentation: box of 1 × 5 mL vial
• NDC/item number: 0143-9510-01
• Manufacturer: HIKMA PHARMACEUTICALS USA INC
• Storage/handling: Store at controlled room temperature according to the current product labeling.
• Status: Rx only

Important safety information: Review the current product labeling for product-specific contraindications, warnings, and precautions before use.

Refer to the current product labeling for complete indications, preparation or administration instructions, contraindications, warnings, precautions, and storage requirements.